Pulmatrix Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $7.8M0.0% YoYTTM through 30 Jun 2026
Net Income -$5.2MTTM through 30 Jun 2026
Free Cash Flow -$4.3MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 0.0% |
| EBITDA Margin | -50.2% |
| Operating Margin | -66.2% |
| Net Margin | -66.1% |
Returns
-135.5%ROE
-124.7%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio12.55x
Net Debt-$4.1Mnet cash position
Cash & Equivalents$2.2M
Quality Metrics
Altman Z-Score-127.84
Piotroski F-Score3 / 9
FCF Margin-55.2%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2024: $7.8M
Diluted EPS-$1.10TTMFY2025: $-1.41
Dividend
No dividend
Capital Allocation
R&D Spend$10K
Capex Intensity5.1%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.